Showing results (1-10 of 435) with videos related to

Sort By:
Pageof 44
Current Drug Targets|March 16, 2013
TGF-Beta signaling manipulation as potential therapy for IBDIrene Marafini, Francesca Zorzi, Sefora Codazza, et al.
Digestive Diseases (Basel, Switzerland)|September 15, 2015
The IL-12/23/STAT Axis as a Therapeutic Target in Inflammatory Bowel Disease: Mechanisms and Evidence in ManIrene Marafini, Erika Angelucci, Francesco Pallone, et al.
Inflammatory Bowel Diseases|September 13, 2014
Targeting integrins and adhesion molecules to combat inflammatory bowel diseaseIrene Marafini, Silvia Sedda, Francesco Pallone, et al.
International Reviews of Immunology|September 18, 2013
Th17 cytokines in inflammatory bowel diseases: discerning the good from the badEdoardo Troncone, Irene Marafini, Francesco Pallone, et al.
World Journal of Gastroenterology|September 19, 2014
Proteinase activated-receptors-associated signaling in the control of gastric cancerSilvia Sedda, Irene Marafini, Roberta Caruso, et al.
International Journal of Molecular Sciences|December 10, 2013
The dual role of Smad7 in the control of cancer growth and metastasisCarmine Stolfi, Irene Marafini, Veronica De Simone, et al.
Mediators of Inflammation|July 26, 2014
An overview of the role of innate lymphoid cells in gut infections and inflammationSilvia Sedda, Irene Marafini, Michele M Figliuzzi, et al.
Plos One|January 26, 2013
Distinct profiles of effector cytokines mark the different phases of Crohn's diseaseFrancesca Zorzi, Ivan Monteleone, Massimiliano Sarra, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|January 5, 2013
Smad7 antisense oligonucleotide-based therapy for inflammatory bowel diseasesFrancesca Zorzi, Erika Angelucci, Silvia Sedda, et al.
Drugs|April 26, 2015
Antisense approach to inflammatory bowel disease: prospects and challengesIrene Marafini, Davide Di Fusco, Emma Calabrese, et al.
Pageof 44